Co-Authors
This is a "connection" page, showing publications co-authored by Jingyuan Liu and Haofeng Xiong.
Connection Strength
0.809
-
Comparative therapeutic efficacy of interferon alfa-2b and combination lopinavir/ritonavir plus interferon alfa-2b against SARS-CoV-2. BMC Infect Dis. 2021 Aug 30; 21(1):885.
Score: 0.241
-
Case Report: Identification of SARS-CoV-2 in Cerebrospinal Fluid by Ultrahigh-Depth Sequencing in a Patient With Coronavirus Disease 2019 and Neurological Dysfunction. Front Med (Lausanne). 2021; 8:629828.
Score: 0.233
-
Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020 05 20; 18(1):206.
Score: 0.221
-
Distinct durability of IgM/IgG antibody responses in COVID-19 patients with differing severity. Sci China Life Sci. 2022 01; 65(1):223-226.
Score: 0.059
-
Differentiating Between 2019 Novel Coronavirus Pneumonia and Influenza Using a Nonspecific Laboratory Marker-Based Dynamic Nomogram. Open Forum Infect Dis. 2020 May; 7(5):ofaa169.
Score: 0.055